Anzeige
Mehr »
Login
Montag, 08.03.2021 Börsentäglich über 12.000 News von 659 internationalen Medien
Mit Vollgas in die Zukunft! Taat Lifestyle zündet den News-Turbo!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PSNF ISIN: US6300873022 Ticker-Symbol: NV3P 
Tradegate
08.03.21
18:58 Uhr
4,200 Euro
-0,260
-5,83 %
Branche
Nanotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
NANOVIRICIDES INC Chart 1 Jahr
5-Tage-Chart
NANOVIRICIDES INC 5-Tage-Chart
RealtimeGeldBriefZeit
4,2004,30020:47

Aktuelle News zur NANOVIRICIDES Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiOvid Therapeutics, KemPharm leads healthcare gainers; Vir Biotechnology, NanoViricides among major losers15
DiMid-Day Market Update: Nasdaq Down 100 Points; NanoViricides Shares Spike Higher7
NANOVIRICIDES Aktie jetzt für 0€ handeln
DiNanoViricides, CHF Solutions leads healthcare gainers; FibroGen, Neuronetics among major losers18
DiNanoViricides Reports 'Strong Effectiveness' for COVID Drugs11
DiNNVC Stock: The COVID-19 Drug News That Has NanoViricides Rocketing Today10
DiThe Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data37
DiNanoViricides shares rally 29% on effectiveness of COVID-19 drug candidates in cell culture studies16
DiNanoViricides, Inc. Pan-coronavirus Clinical Drug Candidates for the Treatment of COVID-19 Are Highly Effective in Pre-clinical Cell Culture Studies Performed in Preparation of FDA Pre-IND Application493SHELTON, CT / ACCESSWIRE / March 2, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicine...
► Artikel lesen
17.02.NanoViricides reports FQ2 results8
17.02.NanoViricides, Inc.: NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2020 - Has Sufficient Cash, Coronavirus Drug Candidate Safe in GLP Safety Toxicology Moving Towards IND1.553SHELTON, CT / ACCESSWIRE / February 17, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines...
► Artikel lesen
16.02.NANOVIRICIDES, INC. - 10-Q, Quaterly Report2
08.02.NanoViricides' Broad-Spectrum Antiviral Drug Candidate Shows Encouraging Action In Preclinical Studies For COVID-194
08.02.NanoViricides's anti-coronavirus candidate was well tolerated in animal studies4
08.02.NanoViricides, Inc.: NanoViricides's Broad-Spectrum Antiviral Drug Candidate for the Treatment of COVID-19 Infections was Well Tolerated in GLP and non-GLP Animal Safety Studies1.385SHELTON, CT / ACCESSWIRE / February 8, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective broad-spectrum antiviral therapies based...
► Artikel lesen
27.01.Broad-Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus Variants, Says NanoViricides, Inc.'s President, Dr. Anil Diwan908SHELTON, CT / ACCESSWIRE / January 27, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective broad-spectrum antiviral therapies based...
► Artikel lesen
19.11.20NANOVIRICIDES, INC. - 8-K, Current Report8
19.11.20NanoViricides, Inc.: NanoViricides Strengthens its Board of Directors with Addition of Industry Veteran Brian Zucker, CPA1.288SHELTON, CT / ACCESSWIRE / November 19, 2020 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a leader in developing novel nanomedicines to treat viral diseases, announced today that Mr. Brian...
► Artikel lesen
17.11.20NanoViricides reports FQ1 results9
17.11.20NanoViricides, Inc.: NanoViricides Has Filed Quarterly Report for Period Ending September 30, 2020 - Has Sufficient Cash, Coronavirus Drug Development Progress1.078SHELTON, CT / ACCESSWIRE / November 17, 2020 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines...
► Artikel lesen
11.11.20NanoViricides, Inc.: NanoViricides Has Engaged Calvert Labs for Safety Pharmacology Studies of Its Drug for the Treatment of COVID-191.543SHELTON, CT / ACCESSWIRE / November 11, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines...
► Artikel lesen
Seite:  Weiter >>
48 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3